Adrie van Bokhoven

10PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Dissociated response to immune checkpoint inhibition in head and neck squamous cell carcinoma is common and exhibits distinct clinical outcomes.

|Apr 06, 2026
Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth.

Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Mar 14, 2024
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis.

Ryan M Baxter, Berenice Cabrera-Martinez, Tusharkanti Ghosh

|Jun 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.

William H Palmer, Laura Ann Leaton, Ana Campos Codo

|Nov 26, 2022
A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.

Laurel B Darragh, Michael M Knitz, Junxiao Hu

Pageof 2

Frequent Collaborators

3 joint publications

Sana D Karam

3 joint publications

Ashesh Thaker

3 joint publications

Thomas Bickett

3 joint publications

Michael M Knitz